Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)

So far, Dimensions has found 32 publications that cite this research output.

Article in Current Opinion in Immunology (March 2023)

Article in Nature Reviews Clinical Oncology (January 2023)

Article in Nature Biotechnology (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.